Treatment resistant schizophrenia is associated with the worst community functioning among severely-ill highly-disabling psychiatric conditions and is the most relevant predictor of poorer achievements in functional milestones
- PMID: 26320028
- DOI: 10.1016/j.pnpbp.2015.08.010
Treatment resistant schizophrenia is associated with the worst community functioning among severely-ill highly-disabling psychiatric conditions and is the most relevant predictor of poorer achievements in functional milestones
Abstract
The aim of this work was to compare achievements in milestones of community functioning in highly disabling psychiatric conditions, including treatment resistant schizophrenia (TRS), schizophrenia (responsive to antipsychotics), bipolar disorder, and anxiety/depressive diseases. Also, we investigated the predictors of community functioning outcomes across several domains. Among consecutive patients screened, 188 met inclusion criteria and 118 ultimately entered the study. Diagnosis of TRS was made by stringent criteria, including historic and perspective evaluations and excluding potential confounding factors. Achievements in functional milestones of everyday living were recorded. Performances in discrete cognitive tasks were assessed. The Positive and Negative Syndrome Scale, the Personal and Social Performance Scale, the Drug Attitude Inventory-10, and the Quality of Life Enjoyment and Satisfaction Questionnaire were administered. TRS patients showed the highest impairment in community functioning among diagnostic groups. TRS was found to have more severe psychopathology, more impaired cognitive functioning, and poorer psychosocial adjustment compared to all the other groups. In the whole sample, the main predictors of community functioning were the diagnostic group (with TRS diagnosis associated with worst functioning) and achievements in the other functional milestones. In psychotic patients, however, the main predictors of community functioning were clinical and psychopathological variables. These results may support the hypothesis that TRS represents a separate schizophrenia subtype, with its own neurobiology, psychopathology and clinical course. Our results identify a group of modifiable predictors to be addressed to prevent community disability.
Keywords: Cognitive; PANSS; Psychosis; Psychosocial; Quality of life.
Copyright © 2015 Elsevier Inc. All rights reserved.
Similar articles
-
Differential cognitive performances between schizophrenic responders and non-responders to antipsychotics: correlation with course of the illness, psychopathology, attitude to the treatment and antipsychotics doses.Psychiatry Res. 2013 Dec 15;210(2):387-95. doi: 10.1016/j.psychres.2013.06.042. Epub 2013 Jul 30. Psychiatry Res. 2013. PMID: 23910239
-
Treatment resistant schizophrenia and neurological soft signs may converge on the same pathology: Evidence from explanatory analysis on clinical, psychopathological, and cognitive variables.Prog Neuropsychopharmacol Biol Psychiatry. 2018 Feb 2;81:356-366. doi: 10.1016/j.pnpbp.2017.09.002. Epub 2017 Sep 5. Prog Neuropsychopharmacol Biol Psychiatry. 2018. PMID: 28887181 Clinical Trial.
-
Clinical evaluation of functional capacity in treatment resistant schizophrenia patients: Comparison and differences with non-resistant schizophrenia patients.Schizophr Res. 2018 Dec;202:217-225. doi: 10.1016/j.schres.2018.06.030. Epub 2018 Jun 20. Schizophr Res. 2018. PMID: 29934250 Clinical Trial.
-
Defining treatment-resistant schizophrenia and response to antipsychotics: a review and recommendation.Psychiatry Res. 2012 May 15;197(1-2):1-6. doi: 10.1016/j.psychres.2012.02.013. Epub 2012 Mar 18. Psychiatry Res. 2012. PMID: 22429484 Review.
-
Assessment of everyday functioning in schizophrenia: implications for treatments aimed at negative symptoms.Schizophr Res. 2013 Nov;150(2-3):353-5. doi: 10.1016/j.schres.2013.04.022. Epub 2013 May 11. Schizophr Res. 2013. PMID: 23668973 Free PMC article. Review.
Cited by
-
Mendelian randomization study of the relationship between blood and urine biomarkers and schizophrenia in the UK Biobank cohort.Commun Med (Lond). 2024 Mar 7;4(1):40. doi: 10.1038/s43856-024-00467-1. Commun Med (Lond). 2024. PMID: 38454150 Free PMC article.
-
Development of an individualized risk calculator of treatment resistance in patients with first-episode psychosis (TRipCal) using automated machine learning: a 12-year follow-up study with clozapine prescription as a proxy indicator.Transl Psychiatry. 2024 Jan 22;14(1):50. doi: 10.1038/s41398-024-02754-w. Transl Psychiatry. 2024. PMID: 38253484 Free PMC article.
-
Alterations of serum neuropeptide levels and their relationship to cognitive impairment and psychopathology in male patients with chronic schizophrenia.Schizophrenia (Heidelb). 2024 Jan 3;10(1):3. doi: 10.1038/s41537-023-00425-1. Schizophrenia (Heidelb). 2024. PMID: 38172494 Free PMC article.
-
Improving outcome of treatment-resistant schizophrenia: effects of cognitive remediation therapy.Eur Arch Psychiatry Clin Neurosci. 2023 Dec 19. doi: 10.1007/s00406-023-01731-6. Online ahead of print. Eur Arch Psychiatry Clin Neurosci. 2023. PMID: 38114732
-
miRNA cargo in circulating vesicles from neurons is altered in individuals with schizophrenia and associated with severe disease.Sci Adv. 2023 Dec;9(48):eadi4386. doi: 10.1126/sciadv.adi4386. Epub 2023 Nov 29. Sci Adv. 2023. PMID: 38019909 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
